| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/09/1994 | EP0506789B1 Cloning vector for use in lactic acid bacteria and a method for constructing the same |
| 03/09/1994 | EP0383751B1 Production of human parathyroid hormone from microorganisms |
| 03/09/1994 | CN1083529A New type recombinant DNA containing luciferase gene and production method of luciferase |
| 03/09/1994 | CN1083528A Coding DNA of deaminizing formaenzyme which can increase heat-durability of same |
| 03/09/1994 | CN1083527A Recombinant entomopoxvirus |
| 03/09/1994 | CN1083524A Deletion mutants as vaccines for cholera |
| 03/08/1994 | US5292662 Position-specific insertion vectors and method of using same |
| 03/08/1994 | US5292658 Cloning and expressions of Renilla luciferase |
| 03/08/1994 | US5292653 Equine herpesvirus 1 tk mutants |
| 03/08/1994 | US5292652 For cleaving Met-Asp bond |
| 03/08/1994 | US5292651 Method for cloning and producing the NaeI restriction endonuclease and methylase |
| 03/08/1994 | US5292646 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 03/08/1994 | US5292643 Fusaric acid resistant genes |
| 03/08/1994 | CA2105594A1 Transgenic non-human mammals with an oncogene under the control of an inducible liver-specific promoter |
| 03/05/1994 | CA2105425A1 Process for the production of protease inhibitors |
| 03/03/1994 | WO1994007538A1 ANTISENSE OLIGONUCLEOTIDES TO B-m^_y^_b^_ PROTO-ONCOGENE |
| 03/03/1994 | WO1994004927A1 Method for diagnosing and monitoring sepsis |
| 03/03/1994 | WO1994004922A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |
| 03/03/1994 | WO1994004706A1 Elimination of false negatives in nucleic acid detection |
| 03/03/1994 | WO1994004699A1 In vitro ligation of foreign dna into large eukaryotic viruses |
| 03/03/1994 | WO1994004698A1 Novel protein and gene coding for the same |
| 03/03/1994 | WO1994004697A1 Novel elafin derivative |
| 03/03/1994 | WO1994004696A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 03/03/1994 | WO1994004695A1 Herpesviral defective vector with rat preproenkephalin gene promoter |
| 03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
| 03/03/1994 | WO1994004693A2 Novel plants and processes for obtaining them |
| 03/03/1994 | WO1994004692A1 Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
| 03/03/1994 | WO1994004690A1 Bispecific immunoadhesins |
| 03/03/1994 | WO1994004689A1 Recombinant toxin with increased half-life |
| 03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
| 03/03/1994 | WO1994004687A1 Modified fungal cells and method for producing recombinant products |
| 03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
| 03/03/1994 | WO1994004685A1 Recombinant antigens and vaccines of bovine ephemeral fever virus |
| 03/03/1994 | WO1994004684A1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
| 03/03/1994 | WO1994004683A1 Bordetella bronchiseptica vaccine |
| 03/03/1994 | WO1994004682A1 Bacteriocin |
| 03/03/1994 | WO1994004681A1 Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof |
| 03/03/1994 | WO1994004680A1 Human interleukin-13 |
| 03/03/1994 | WO1994004679A1 Method for making humanized antibodies |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004677A1 The use of cd4 plasma membrane vesicles (pmv) as a therapeutic agent for aids |
| 03/03/1994 | WO1994004676A1 Stress protein epitopes |
| 03/03/1994 | WO1994004675A2 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004673A1 Fungal promoters active in the presence of glucose |
| 03/03/1994 | WO1994004672A1 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | WO1994004670A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | WO1994004669A1 Mice having cftr defect as model for cystic fibrosis |
| 03/03/1994 | WO1994004668A1 Regulation of the sinusal rhythm by a human membrane receptor sequence |
| 03/03/1994 | WO1994004667A1 Targeted replacement of a gene without endogenous and selectable residual sequences |
| 03/03/1994 | WO1994004663A1 Thermostable sequence-specific endonucleases |
| 03/03/1994 | WO1994004661A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | WO1994004660A1 Insect viruses and their uses in protecting plants |
| 03/03/1994 | WO1994004659A1 A novel b-lymphoma cell line and antigen |
| 03/03/1994 | WO1994004651A1 Liquid detergents containing a peptide aldehyde |
| 03/03/1994 | WO1994004573A1 cDNA CLONE ENCODING AN EXPRESSIBLE GABA TRANSPORTER |
| 03/03/1994 | WO1994004571A1 A substrate for the epidermal growth factor receptor kinase |
| 03/03/1994 | WO1994004567A1 A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
| 03/03/1994 | WO1994004565A2 Ipnv vaccine |
| 03/03/1994 | WO1994004564A1 T cell epitopes of ryegrass pollen allergen |
| 03/03/1994 | WO1994004562A1 Mammalian gap-43 compositions and methods of use |
| 03/03/1994 | WO1994004561A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | WO1994004560A1 Schwann cell mitogenic factor, its preparation and use |
| 03/03/1994 | WO1994004558A1 Method for generating and screening useful peptides |
| 03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004552A1 Opioid receptor genes |
| 03/03/1994 | WO1994004551A1 Method of obtaining sodium salt of native dna |
| 03/03/1994 | WO1994004301A1 Quick-change tool holder with center-height adjustment mechanism |
| 03/03/1994 | WO1994004196A1 Tumour therapy |
| 03/03/1994 | WO1994004183A1 Methods for effecting a prolonged reduction in measurable fat content and medicaments for use therein |
| 03/03/1994 | WO1994004179A1 Method for inhibiting hiv replication using il-4 |
| 03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
| 03/03/1994 | WO1994004137A1 Antisense oligonucleotides to cyclin d1 proto-oncogene |
| 03/03/1994 | WO1994004032A1 Composition and method for altering dna sequences by homologous recombination |
| 03/03/1994 | WO1994001572A3 Maize pollen-specific polygalacturonase gene |
| 03/03/1994 | WO1994001451A3 Method for modification of recombinant polypeptides |
| 03/03/1994 | WO1993023550A3 Activation of oligomerizing receptors by using fused receptor ligands |
| 03/03/1994 | WO1993022055A3 Fluid handling in microfabricated analytical devices |
| 03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
| 03/03/1994 | DE4228787A1 Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate New HIV-1 isolates of subtype vaccine against HIV-1 virus infection of this subtype and methods for their production, use of the HIV-1 virus isolates |
| 03/03/1994 | CA2393847A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
| 03/03/1994 | CA2143326A1 Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
| 03/03/1994 | CA2143316A1 Novel plants and processes for obtaining them |
| 03/03/1994 | CA2143308A1 Translocation signal facilitated nuclear delivery of macromolecules |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2142990A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase |
| 03/03/1994 | CA2142989A1 A novel b-lymphoma cell line and antigen |
| 03/03/1994 | CA2142902A1 Virus obtainable from human neuroblastoma cells |
| 03/03/1994 | CA2142872A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |
| 03/03/1994 | CA2142860A1 Human interleukin-13 |
| 03/03/1994 | CA2142602A1 Fungal promoters active in the presence of glucose |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/03/1994 | CA2141602A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | CA2141583A1 Insect viruses and their uses in protecting plants |
| 03/03/1994 | CA2140280A1 Bispecific immunoadhesins |
| 03/03/1994 | CA2117270A1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
| 03/02/1994 | EP0585109A2 N-Acetylglucosaminyl transferase, gene coding therefor, corresponding vectors and transformed hosts, processes for production thereof |